Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Ocugen to Participate in Upcoming October Investor and Industry Conferences

$OCGNPress releaseSep 29, 2026, 7:02 AM ETRead the release

Ocugen announced its executive leadership will present at two October investor and industry conferences. CEO Dr. Shankar Musunuri will moderate a panel on alternative life-sciences financing at H.C. Wainwright's Biotech on Tap in Munich on October 1, and speak on cell and gene therapy commercialization at the Cell & Gene Meeting on the Mesa in Phoenix on October 6.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.